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Ischemic stroke is a condition increasingly recognized in dogs; however, the number
of publications on dogs with ischemic stroke is still limited and hemostatic parameters
are infrequently reported. D-dimer levels have been shown to be elevated in people
with acute ischemic stroke compared to a healthy control population and it has
been proposed that a normal D-dimer can be used to exclude thromboembolism
in dogs. In this case series, we report hemostatic parameters, including D-dimer
and thromboelastography (TEG) along with clinical and imaging findings for five dogs
diagnosed with ischemic stroke. All dogs had a normal D-dimer concentration on
presentation. A hypercoagulable state was identified in two dogs based on the results of
the TEG, and was suspected in the remaining three cases based on a shortened TEG clot
reaction time. Based on the findings in the present cases, a D-dimer within the normal
reference range does not seem an appropriate negative predictor for canine ischemic
stroke. The demonstration of a possible hypercoagulable state, as identified by the TEG,
is an interesting finding which should be explored further to help reveal predisposing
hypercoagulable conditions in dogs with ischemic stroke.
Keywords: ischemic stroke, infarction, cerebrovascular accident, hemostatic parameters, D-dimer,
hypercoagulability, thromboelastography, TEG
BACKGROUND
Ischemic stroke is defined as an acute interruption of the blood supply to a dependent area of
the brain caused by a thrombotic or thromboembolic event, resulting in infarction with loss of
neurological function of the related vascular territory (1). The condition is increasingly recognized
in dogs, and the diagnosis is based on an acute onset of non-progressive neurological signs in
combination with characteristic magnetic resonance imaging (MRI) findings (2, 3).
In humans, a reliable and inexpensive diagnostic test and predictor of prognosis and risk
of recurrence is being sought for ischemic stroke (4). It has been shown that plasma D-dimer
levels are elevated in acute ischemic stroke compared to healthy control populations (4–11).
As D-dimers are solely derived from the degradation of cross-linked fibrin monomers in stable
clots, they are specific for active coagulation and fibrinolysis. A normal D-dimer in humans is
considered a valuable negative predictor for intravascular thrombotic processes, especially in cases
if central venous thrombosis (12). However, normal D-dimer levels cannot rule out a diagnosis
of ischemic stroke in people and should not replace clinical and radiological evaluation (4). The
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use of D-dimer has shown promising results when screening
for thromboembolic disease and disseminated intravascular
coagulation (DIC) in dogs, and it has been proposed that
a normal D-dimer concentration can be used to exclude
thromboembolism in suspected cases (13, 14).
Thromboelastography (TEG) is a hemostatic diagnostic tool
used for assessment of coagulation. It is an analytical method
that enables global assessment of hemostatic function with
evaluation of both plasma and cellular components (15). TEG
has been successfully validated for the assessment of DIC and
bleeding disorders in dogs (16, 17), and the assay has gained
recent practical application in people with acute ischemic stroke
for assessing coagulation status and response to thrombolytic
therapy (18).
The number of publications in dogs with ischemic stroke
where hemostatic parameters have been reported is limited
(19–21). The usefulness of coagulation tests such as D-dimer
concentrations and TEG in the diagnosis and management of
canine ischemic stroke is therefore still uncertain. In this case
series we describe clinical and MRI findings as well as hemostatic
parameters including D-dimer and TEG for five dogs diagnosed
with ischemic stroke.
CASE PRESENTATIONS
For the following cases TEG measurements were compared with
a previously established reference range for citrated plasma (22)
and whole blood (23). TEG was performed on citrated plasma
in cases 1–3, as the samples needed to be frozen for transport
before analysis could take place, and on citrated whole blood in
cases 4–5.
Case 1
A 13-year, nine-month-old male neutered Yorkshire terrier
presented with a peracute onset of left-sided circling, and
a history of polyuria and polydipsia. The general physical
examination identified a grade III/VI systolic heart murmur and
obesity. On neurological examination, the dog was obtunded and
was circling in small circles toward the left. The proprioceptive
positioning was absent in the right thoracic and pelvic limbs. The
remainder of the neurological examination was unremarkable,
and a neurolocalization of left forebrain was determined.
Routine hematology was within normal limits, while serum
biochemistry results included a moderately increased alkaline
phosphatase activity (731 U/L; RI: 23-212 U/L). Noninvasive
blood pressure (NIBP) assessment using Doppler identified
a systolic pressure of 200–210 mmHg. An echocardiogram
demonstrated mitral regurgitation consistent with presumed
preclinical degenerative mitral valve disease. Urine-specific
gravity was 1.020. Urine chemistry dipstick analysis was
consistent with proteinuria (3+; RI: negative to trace), and
a urine protein:creatinine (UPC) ratio was elevated (3.97;
RI: 0-1). Urine sediment examination was normal, and urine
culture was negative. Prothrombin time (PT), activated partial
thromboplastin time (aPTT), fibrinogen, and D-dimer were all
within normal limits. A shortened reaction time (R) and split
point (SP) were seen on TEG analysis performed on citrated
plasma (Table 1).
An MRI scan of the brain (VetMR Grande 0.35T, Esaote,
Genova, Italy) was performed under general anesthesia and
included T2-weighted (T2W) transverse images, fluid attenuated
inversion recovery (FLAIR) dorsal images, and short-TI
inversion recovery transverse images. Sagittal, transverse and
dorsal T1-weighted (T1W) images were acquired before and
after intravenous (IV) administration of gadolinium contrast
(0.1 mmol/kg, gadolinium demeglumine). An intra-axial, focal,
well-defined and sharply demarcated lesion was identified
within the left thalamus (Figure 1). The lesion was hypo- to
isointense compared to normal gray matter on T1W images and
hyperintense on T2W and FLAIR sequences. The lesion did not
show enhancement after gadolinium administration, and there
was no evidence of mass effect. These findings were suggestive of
an extensive dorsal thalamic infarct.
Further investigations were performed to evaluate for
evidence of predisposing causes for cerebrovascular disease and
hypertension. Bilateral adrenomegaly was seen on abdominal
ultrasound and a low-dose dexamethasone suppression test
[basal cortisol: 204 nmol/L (RI: 27.5–125 nmol/L), 4 h post
suppression: 34 nmol/L (RI: <40 nmol/L), 8 h post suppression:
168 nmol/L (RI: <40 nmol/L)] was consistent with pituitary
dependent hyperadrenocorticism. Thoracic radiographs
were unremarkable.
Treatment consisted of amlodipine (1 mg/kg PO q12 h; Istin
5mg tablets, Pfizer Limited, Kent, UK), enalapril (0.5 mg/kg
PO q24h; Enacard 2.5mg tablets, Merial Animal Health, Harlow
Essex, UK) and trilostane (5 mg/kg PO q24h; Vetoryl 30mg
tablets, Dechra, Shrewsbury, UK). The dog was hospitalized for
seven days and during this time showed a gradual neurological
improvement; the systolic blood pressure had stabilized around
170mmHg at discharge. On reassessment 10 days after discharge,
the dog was only showing mild proprioceptive deficits on the
right side. The dog was lost to follow-up thereafter.
Case 2
A 10-year, 10-month-old male neutered Shih Tzu presented for
further investigation of a peracute onset of lethargy and left-
sided circling. The general physical examination was normal.
On neurological examination, the dog was circling to the left,
had decreased proprioceptive positioning of the right thoracic
and pelvic limbs and a decreased menace response on the
right side. The remainder of the neurological examination was
unremarkable, and the findings were considered consistent with
a left forebrain neurolocalization.
Routine hematology and serum biochemistry was normal,
and serum thyroxin and thyroid-stimulating hormone (TSH)
concentrations were within normal limits. Urine-specific gravity
was 1.018, urine chemistry dipstick analysis and sediment
examination, UPC ratio and urine culture were all unremarkable.
Assessment of NIBP using Doppler identified a systolic pressure
of 170mmHg. Fibrinogen, PT, aPTT, andD-dimer were all within
normal limits. A shortened R time and SP were seen on TEG
analysis on citrated plasma (Table 1).
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TABLE 1 | Hemostatic parameters for ischemic stroke patients.
Case 1a Case 2a Case 3a Case 4b Case 5b Reference interval
Platelets (109/L) 471 317 390 183* 288 200–500
PT (s) 5.7 8.6 6.8 7.5 6.8 <9.0
aPTT (s) 12.4 9.8 11.8 10.0 9.9 <12.5
Fibrinogen (g/L) 2.46 2.86 1.72 5.14* 1.67 1–4
D-dimer (mg/L) <0.1 0.3 0.1 0.1 0.2 <0.5
TEG parameters
R (min) 2.1* 2.6* 2.1* 5.4 2.7* 2.97–4.75c; 2.8–8.7d
K (min) – – – 1.5* 1.8* 2.3–7.7d
SP (min) 1.9* 2.1* 1.8* – – 2.51–3.81c
α (◦) 57.9 51.2 58.3 70* 65.5* 37.6–58.4c; 27.5–58.7d
MA (mm) 17.4 17.1 16.84 69.3* 62.1* 12.18–17.82c; 39–59d
G (dyn/cm2) – – – 11268* 8182* 3200–7200d
aPTT activated partial thromboplastin time; G global clot strength; K clotting time; MA maximum amplitude; PT prothrombin time; R reaction time; SP split point; TEG
thromboelastography; α angle.
aTEG performed on citrated plasma.
bTEG performed on citrated whole blood.
cReference values for citrated plasma (22).
dReference values for citrated whole blood (23).
* Indicates values outside the reference range.
FIGURE 1 | Case 1 T2-weighted (T2W) FLAIR dorsal image of the brain (A), and T2W (B) and T1-weighted (T1W) post contrast (C) transverse images at the level of
the thalamus revealed an intra-axial well demarcated lesion to the left of the midline consistent with a dorsal extensive thalamic infract. The lesion (indicated by arrows)
is hyperintense compared to normal gray matter on T2W sequences and hypo- to isointense on T1W sequences.
An MRI scan of the brain using the same protocol and
scanner as in case 1 was performed under general anesthesia.
There was an extensive intra-axial, focal, well-demarcated lesion
affecting the cerebral gray matter extending from the left
frontal lobe to the rostral aspects of the left temporal lobe.
The lesion was T2W and FLAIR hyperintense compared to
normal gray matter and T1W hypointense. There was evidence
of mild mass effect and there was no contrast enhancement.
The findings were consistent with an ischemic stroke affecting
the vascular territory of the left middle cerebral artery. CSF
collected from the cerebellomedullary cistern was unremarkable.
Abdominal ultrasound and thoracic radiographs were performed
to evaluate for predisposing causes of the cerebrovascular event.
No abnormalities were detected and accordingly no underlying
cause for the ischemic stroke could be identified.
The dog improvedwith time andwas discharged fromhospital
72 h after admission. The dog made a near to full recovery within
14 days, and was neurologically normal at re-assessment five
months later.
Case 3
A seven-year, five-month-old male neutered Shih Tzu presented
for further investigation of a peracute onset of a head tilt and
loss of balance. The general physical examination was normal. On
neurological examination, the dog was lethargic with a moderate
left head tilt. The dog was non-ambulatory due to severe ataxia
affecting all four limbs; with support the dog was dysmetric with
hypermetria affecting the right thoracic and pelvic limbs. The
remainder of the neurological examination was unremarkable,
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and a neurolocalization of right cerebellum was made, suspecting
paradoxical vestibular disease.
Routine hematology, serum biochemistry, and standard
urinalysis were normal. Serum thyroxin, TSH and an ACTH
stimulation test were also within normal limits. Assessment of
NIBP using Doppler identified a systolic pressure of 160–165
mmHg. Fibrinogen, PT, aPTT, and D-dimer were all within
normal limits. A shortened R time and SP were seen on TEG
analyses performed on citrated plasma (Table 1).
An MRI scan of the brain using the same protocol and
scanner as in case 1 was performed under general anesthesia.
An intra-axial, focal, well-defined and sharply demarcated
lesion was identified within the right cerebellar hemisphere
(Figure 2). The lesion was hypointense compared to normal
gray matter on T1W images, hyperintense on T2W, and FLAIR
sequences and mainly affected the gray matter. The lesion
did not show enhancement after gadolinium administration,
and there was no evidence of mass effect. These findings
were consistent with an ischemic stroke affecting the territory
of the right rostral cerebellar artery. Supracollicular fluid
accumulation was also evident, a finding that was considered to
be incidental. CSF collected from the cerebellomedullary cistern
was unremarkable. No underlying cause for the ischemic stroke
could be identified.
The dog improvedwith time andwas discharged fromhospital
after five days. On re-examination 14 days after discharge the dog
was only showing mild hypermetria of the right thoracic limb, he
was lost to follow-up thereafter.
Case 4
A six-year, two-month-old female cavalier King Charles spaniel
presented with a history of a peracute onset of lethargy
and circling to the right. The dog presented to the hospital
seven days after the onset of clinical signs, and had already
improved clinically, according to the owner. The general physical
examination was normal. On neurological examination, the dog
showed delayed proprioceptive positioning on the left thoracic
and pelvic limbs and an inconsistent menace response on the left
side. Circling was not detected on presentation. The remainder of
the neurological examination was normal, and the findings were
considered consistent with a right forebrain neurolocalization.
Mild thrombocytopenia with the presence of
macrothrombocytes was seen on routine hematology
(Table 1). Serum biochemistry and standard urinalysis
were unremarkable. Serum thyroxin and TSH were also
within normal limits. Assessment of NIBP using oscillometry
identified a systolic pressure of 170 mmHg. D-dimer, PT
and aPTT were within normal limits whereas the fibrinogen
level was mildly increased (Table 1). TEG analysis performed
on citrated whole blood was considered hypercoagulable
with a normal R time, shortened clotting time (K) time, and
increased maximum amplitude (MA), angle (α), and global
clot strength (G value) (Table 1). The TEG tracing is shown in
Figure 3.
An MRI scan of the brain (VetMR 0.2T, Esaote, Genova,
Italy) was performed under general anesthesia and included
T2W sagittal and transverse images and FLAIR transverse
images. Sagittal and transverse T1W images were acquired
before and after IV administration of gadolinium contrast
(0.1 mmol/kg, gadolinium dimeglumine). In the right frontal
and rostral aspects of the temporal lobe there was an intra-
axial, focal, well-defined, and sharply demarcated lesion. The
lesion was hyperintense on T2W and FLAIR sequences and
hypointense on T1W images compared to normal gray matter.
The changes were particularly evident within the cortical
gray matter. The lesion was associated with mild mass effect
and there was no contrast enhancement. These findings were
suggestive of an ischemic stroke affecting the territory of the
right middle cerebral artery. Changes consistent with Chiari-
like malformation and a left-sided otitis media with effusion
were also seen; both were considered incidental findings.
Further investigations to evaluate for a predisposing cause
for cerebrovascular disease was not undertaken based on the
owner’s decision.
The dog improved with time, and was considered
neurologically normal at re-examination 49 days after discharge,
with no recurrence of neurological deficits.
Case 5
A six-year, 11-month-old male Weimaraner presented with a
five-day history of a peracute onset of a right-sided head tilt
and loss of balance. The signs were improving on presentation.
The general physical examination was normal. On neurological
examination, the dog had an alert mentation, a mild right-
sided head tilt, cerebellovestibular ataxia, and a broad-based
stance affecting all limbs. There was occasional falling to
the right with delayed and dysmetric hopping affecting all
limbs. The remainder of the neurological examination was
unremarkable, and a neurolocalization of right cerebellum
was made.
Routine hematology, serum biochemistry, and standard
urinalysis were unremarkable. Serum thyroxin and TSH were
also within normal limits. Assessment of NIBP using oscillometry
identified a systolic pressure of 170–175 mmHg. Fibrinogen,
PT, aPTT, and D-dimer were all within normal limits. TEG
analysis on citrated whole blood was considered hypercoagulable
with a shortened R and K time, and an increased MA, α, and
G value (Table 1).
An MRI scan of the brain using the same protocol and
scanner as in case 4 was performed under general anesthesia.
There was an intra-axial, focal and sharply demarcated wedge-
shaped lesion within the right paravermis and rostrodorsal
aspect of the cerebellar cortex. The lesion was hyperintense
on T2W and FLAIR images compared to normal gray
matter, and T1W hypointense. There was no mass effect or
evidence of enhancement after contrast medium administration.
These findings were most consistent with an ischemic stroke
affecting the territory of the right rostral cerebellar artery. CSF
collected from the cerebellomedullary cistern was normal. No
predisposing cause for the ischemic stroke could be identified in
this case.
The dog improved with time and was considered
neurologically normal on re-assessment two months
after presentation.
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FIGURE 2 | Case 3 T2-weighted (T2W) FLAIR dorsal image of the brain (A), and T2W (B), and T1-weighted (T1W) post contrast (C) transverse images at the level of
the caudal cerebellar peduncles revealed an intra-axial well demarcated lesion to the right of the midline consistent with an ischemic stroke affecting the right rostral
cerebellar artery. The lesion (indicated by arrows) is hyperintense compared to normal gray matter on T2W sequences and hypo- to isointense on T1W sequences.
FIGURE 3 | Thromboelastographic (TEG) tracing for case 4 performed on citrated whole blood. The TEG was considered hypercoagulable based on a normal
reaction time (R), shortened clotting time (K), increased angle and maximum amplitude (MA), and increased clot strength (G). Dotted lines represent reference intervals
and solid lines represent the test result.
DISCUSSION
In this report we describe five dogs with ischemic stroke, all with
normal D-dimer concentrations, suggesting that D-dimer is of
little value as a negative predictor for arterial thromboembolic
disease in the central nervous system, as opposed to other
thromboembolic diseases in dogs (13, 14). In humans, a normal
D-dimer has been shown to be a valuable negative predictor
to rule out intravascular thrombotic processes, in particular in
cases of venous thromboembolic disease such as central venous
thrombosis and deep venous thrombosis (4, 12, 24, 25). D-
dimer has also been shown to be significantly elevated in human
ischemic stroke compared to healthy control populations (5–
11), however, a normal D-dimer cannot rule out a diagnosis of
ischemic stroke in people (4). In dogs, cerebral venous occlusion
is reported but is thought to be a rare cause of ischemia due
to abundant anastomoses (26, 27). In the present cases, normal
D-dimer levels may be explained by arterial rather than venous
occlusions. Normal D-dimer values have also previously been
described in eight dogs diagnosed with ischemic stroke; detailed
results were, however, not reported (20, 21).
In the present study, the D-dimer levels in cases 4 and 5 were
measured seven and five days after the onset of clinical signs,
respectively, and it cannot be excluded that the late sampling
influenced the measured concentrations. However, in human
patients following ischemic stroke, D-dimer levels gradually
increase peaking around two weeks after onset of clinical signs,
remain high for several weeks, and then gradually decrease (4).
Two of the dogs in this case series were characterized
as hypercoagulable based on shortened R and K times, and
increased α and MA. The G value in these two dogs was >7,200
dyn/cm2 also indicating an increased clot strength (23). In the
remaining three cases, TEG analysis was performed on citrated
plasma which may lack important cellular factors. Even though
it is more difficult to apply these results in a clinical setting,
all three dogs had a shortened R time and SP, compared to a
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previously established reference range on plasma TEG, indicating
a hypercoagulable state also in these dogs.
TEG has also been investigated in human ischemic stroke,
where the analyses suggest the existence of a hypercoagulable
state in 29–41% of the patients (18, 28). Acute ischemic stroke
patients with hypercoagulable TEG had shorter R and K times
and a greater α indicating a faster clotting. Variable clot strength
was detected in these patients, with 24.5% having an increased
clot strength indicated by an elevated G value (18). In canine
stroke, the use of TEG has only been reported in four greyhounds
diagnosed with ischemic stroke (20). The analysis was reported
to be normal in these dogs compared to previously reported
reference values (20, 29). Greyhounds are, however, reported to
have slower clotting kinetics and weaker clot strengths compared
to non-greyhound dogs (29). The TEG results from greyhounds
with ischemic stroke may therefore not be representative for
non-greyhound dogs with the same diagnosis.
A hypercoagulable state has previously been suspected in
four dogs diagnosed with ischemic stroke based on routine
hemostatic assays and comorbidities (19). Routine hemostatic
assays, however, have poor sensitivity for the detection of
hypercoagulability, whereas TEG has been evaluated for its
capacity to provide early, sensitive detection of a hypercoagulable
state (15). Even though the results in the present study are
based on a small sample size, the demonstration of a possible
hypercoagulable state as suggested by the TEG results is an
interesting finding, which should be explored further to help
reveal predisposing hypercoagulable conditions in dogs with
ischemic stroke. It is, however, difficult to know if the TEG results
predated the stroke or if they were a result thereof.
Hypercoagulable conditions can cause thromboembolic
disease, and predisposing causes of hypercoagulable states
such as hyperadrenocorticism, protein-losing nephropathy,
splenic hemangiosarcoma, and bacterial endocarditis have been
described in dogs with ischemic stroke (19, 30–32). In this
case series, only one dog was diagnosed with a comorbidity
(pituitary-dependent hyperadrenocorticism) that could explain
a hypercoagulable state. The dogs were, however, not evaluated
for primary hypercoagulable states.
The diagnosis of ischemic stroke in the current cases was
based on the peracute presentation of focal non-progressive
neurological signs and imaging characteristics on conventional
MRI sequences. Diffusion-weighted and gradient echo imaging
were however not performed due to the low field strength
magnets used for these cases. This is a limitation as additional
hemorrhagic lesions cannot completely be excluded.
In conclusion, a normal D-dimer does not seem an
appropriate negative predictor for canine ischemic stroke and
should not replace either clinical or radiological evaluation.
The application of TEG to canine ischemic stroke patients may
contribute with important information on the global hemostatic
conditions of these animals and may eventually be used to
guide and monitor thrombolytic therapy.
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